Preclinical safety profile of trastuzumab emtansine (T-DM1): mechanism of action of its cytotoxic component retained with improved tolerability.
Toxicol Appl Pharmacol
; 273(2): 298-313, 2013 Dec 01.
Article
in En
| MEDLINE
| ID: mdl-24035823
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Blood Platelets
/
Cytotoxins
/
Antibodies, Monoclonal, Humanized
/
Maytansine
/
Antineoplastic Agents
Type of study:
Clinical_trials
Limits:
Animals
/
Female
/
Humans
/
Male
Language:
En
Journal:
Toxicol Appl Pharmacol
Year:
2013
Type:
Article